Division for Heart Disease and Stroke Prevention, CDC, Atlanta, GA, USA.
IHRC, Inc. Atlanta, GA, USA.
Adv Nutr. 2020 Sep 1;11(5):1174-1200. doi: 10.1093/advances/nmaa049.
As the science surrounding population sodium reduction evolves, monitoring and evaluating new studies on intake and health can help increase our understanding of the associated benefits and risks. Here we describe a systematic review of recent studies on sodium intake and health, examine the risk of bias (ROB) of selected studies, and provide direction for future research. Seven online databases were searched monthly from January 2015 to December 2019. We selected human studies that met specified population, intervention, comparison, outcome, time, setting/study design (PICOTS) criteria and abstracted attributes related to the study population, design, intervention, exposure, and outcomes, and evaluated ROB for the subset of studies on sodium intake and cardiovascular disease risks or indicators. Of 41,601 abstracts reviewed, 231 studies were identified that met the PICOTS criteria and ROB was assessed for 54 studies. One hundred and fifty-seven (68%) studies were observational and 161 (70%) focused on the general population. Five types of sodium interventions and a variety of urinary and dietary measurement methods were used to establish and quantify sodium intake. Five observational studies used multiple 24-h urine collections to assess sodium intake. Evidence mainly focused on cardiovascular-related indicators (48%) but encompassed an assortment of outcomes. Studies varied in ROB domains and 87% of studies evaluated were missing information on ≥1 domains. Two or more studies on each of 12 outcomes (e.g., cognition) not previously included in systematic reviews and 9 new studies at low ROB suggest the need for ongoing or updated systematic reviews of evidence on sodium intake and health. Summarizing evidence from assessments on sodium and health outcomes was limited by the various methods used to measure sodium intake and outcomes, as well as lack of details related to study design and conduct. In line with research recommendations identified by the National Academies of Science, future research is needed to identify and standardize methods for measuring sodium intake.
随着关于人群钠减少的科学研究不断发展,监测和评估新的关于摄入量和健康的研究可以帮助我们更好地理解相关的益处和风险。在这里,我们描述了一项关于钠摄入量与健康的最新研究的系统综述,检查了选定研究的偏倚风险(ROB),并为未来的研究提供了方向。从 2015 年 1 月到 2019 年 12 月,我们每月在七个在线数据库中进行搜索。我们选择了符合特定人群、干预、比较、结局、时间、设置/研究设计(PICOTS)标准的人体研究,并提取了与研究人群、设计、干预、暴露和结局相关的属性,并对纳入的钠摄入量与心血管疾病风险或指标相关的研究子集进行了 ROB 评估。在审查的 41601 篇摘要中,有 231 篇研究符合 PICOTS 标准,对 54 篇研究进行了 ROB 评估。其中 157 项(68%)为观察性研究,161 项(70%)为针对普通人群的研究。五种类型的钠干预措施和各种尿液和饮食测量方法被用于确定和量化钠摄入量。有 5 项观察性研究使用多次 24 小时尿液收集来评估钠摄入量。证据主要集中在心血管相关指标上(48%),但也涵盖了各种结局。研究在 ROB 领域存在差异,87%的研究在至少一个领域存在信息缺失。在以前未包括在系统评价中的 12 个结局(如认知)中的每个结局都有两项或更多的研究,以及 9 项新的低 ROB 研究,这表明需要对钠摄入与健康的证据进行持续或更新的系统评价。由于用于测量钠摄入量和结局的方法各不相同,以及缺乏与研究设计和实施相关的详细信息,因此对钠与健康结局的评估证据进行总结受到限制。根据美国国家科学院确定的研究建议,未来的研究需要确定和标准化测量钠摄入量的方法。